CONSUN PHARMA (01681) spent HK$2.0967 million to repurchase 140,000 shares on December 15th.
Kang Chan Pharmaceuticals (01681) announced that on December 15, 2025, the company spent HK$2.0967 million to repurchase 140,000 shares at a repurchase price of HK$14.9-15.0 per share.
CONSUN PHARMA (01681) announced on December 15, 2025, that the company will spend 2.0967 million Hong Kong dollars to repurchase 140,000 shares at a repurchase price of 14.9-15.0 Hong Kong dollars per share.
Related Articles
Technology stock strategy for 2026: Anchoring quality targets of Hang Seng Technology, Caitong recommended these 20 stocks.
HK Stock Market Move | Car stocks continue to fall, November car sales at the retail end remain low. JP Morgan predicts that demand will continue to be weak in December and the first quarter of next year.
HK Stock Market Move | CLOUDBREAK-B(02592) dropped nearly 15% once. CBT-199, an ophthalmology candidate drug, has submitted a new drug clinical trial application in the United States.
Technology stock strategy for 2026: Anchoring quality targets of Hang Seng Technology, Caitong recommended these 20 stocks.
HK Stock Market Move | Car stocks continue to fall, November car sales at the retail end remain low. JP Morgan predicts that demand will continue to be weak in December and the first quarter of next year.
HK Stock Market Move | CLOUDBREAK-B(02592) dropped nearly 15% once. CBT-199, an ophthalmology candidate drug, has submitted a new drug clinical trial application in the United States.
RECOMMEND
Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025
Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025
Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025
